Leukocyte Cell-Derived Chemotaxin-2: It's Role in Pathophysiology and Future in Clinical Medicine

被引:35
|
作者
Slowik, V. [1 ]
Apte, U. [2 ]
机构
[1] Childrens Mercy Hosp & Clin, Dept Gastroenterol Hepatol & Nutr, 2401 Gillham Rd, Kansas City, MO 64108 USA
[2] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd,MS1018, Kansas City, KS 66160 USA
来源
关键词
NEWLY RECOGNIZED PROTEIN; AMINO-ACID-SEQUENCE; BETA-CATENIN; INSULIN-RESISTANCE; HEPATOCELLULAR-CARCINOMA; CHEMOTACTIC FACTOR-2; CHONDROMODULIN-II; MOLECULAR-CLONING; STRUCTURAL-CHARACTERIZATION; PLECOGLOSSUS-ALTIVELIS;
D O I
10.1111/cts.12469
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
[No abstract available]
引用
收藏
页码:249 / 259
页数:11
相关论文
共 50 条
  • [31] Leukocyte cell-derived chemotaxin 2 [LECT2] regulates neuritic extension and branching
    Koshimizu, Yohei
    Ohtomi, Michiko
    NEUROSCIENCE RESEARCH, 2007, 58 : S87 - S87
  • [32] Serum leukocyte cell-derived chemotaxin 2 level is associated with atopic dermatitis patients
    Zhao, Keyu
    Xu, Feng
    Jiang, Xinyu
    Chen, Jiong
    Zhu, Xiaoxia
    Zhou, Qiongyan
    Xu, Suling
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 11006 - 11012
  • [33] Serum Leukocyte Cell-Derived Chemotaxin 2 (LECT2) Level Is Associated with Osteoporosis
    Wang, Qiang
    Xu, Feng
    Chen, Jiong
    Xie, Yan-Qing
    Xu, Su-Ling
    He, Wen-Ming
    LABORATORY MEDICINE, 2023, 54 (01) : 106 - 111
  • [34] Reduced serum level of leukocyte cell-derived chemotaxin 2 is associated with the presence of diabetic retinopathy
    Okumura, Akinori
    Unoki-Kubota, Hiroyuki
    Yoshida-Hata, Natsuyo
    Yamamoto-Honda, Ritsuko
    Yamashita, Shigeo
    Iwata, Minoru
    Tobe, Kazuyuki
    Kajio, Hiroshi
    Noda, Mitsuhiko
    Katai, Naomichi
    Yamagoe, Satoshi
    Kaburagi, Yasushi
    CLINICA CHIMICA ACTA, 2016, 463 : 145 - 149
  • [35] Plasma half-life and tissue distribution of leukocyte cell-derived chemotaxin 2 in mice
    Akihiro Kikuchi
    Hiroaki Takayama
    Hirohiko Tsugane
    Kazuhiro Shiba
    Keita Chikamoto
    Tatsuya Yamamoto
    Seiichi Matsugo
    Kiyo-aki Ishii
    Hirofumi Misu
    Toshinari Takamura
    Scientific Reports, 10
  • [36] Elevated serum levels of leukocyte cell-derived chemotaxin 2 are associated with the prevalence of metabolic syndrome
    Zheng, Xialei
    Lu, Junmi
    Xiang, Shaojun
    Zou, Pu
    Chen, Hao
    Liu, Jing
    Zeng, Cheng
    He, Yuhu
    ACTA DIABETOLOGICA, 2024, 61 (05) : 643 - 655
  • [37] Plasma leukocyte cell-derived chemotaxin 2 is associated with the severity of systemic inflammation in patients with sepsis
    Ando, Kazuyoshi
    Kato, Hidehito
    Kotani, Toru
    Ozaki, Makoto
    Arimura, Yutaka
    Yagi, Junji
    MICROBIOLOGY AND IMMUNOLOGY, 2012, 56 (10) : 708 - 718
  • [38] Plasma half-life and tissue distribution of leukocyte cell-derived chemotaxin 2 in mice
    Kikuchi, Akihiro
    Takayama, Hiroaki
    Tsugane, Hirohiko
    Shiba, Kazuhiro
    Chikamoto, Keita
    Yamamoto, Tatsuya
    Matsugo, Seiichi
    Ishii, Kiyo-aki
    Misu, Hirofumi
    Takamura, Toshinari
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [39] Elevated serum levels of leukocyte cell-derived chemotaxin 2 are associated with the prevalence of metabolic syndrome
    Xialei Zheng
    Junmi Lu
    Shaojun Xiang
    Pu Zou
    Hao Chen
    Jing Liu
    Cheng Zeng
    Yuhu He
    Acta Diabetologica, 2024, 61 : 643 - 655
  • [40] Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis
    Yoo, Hye Jin
    Hwang, Soon Young
    Choi, Ju-Hee
    Lee, Hyun Jung
    Chung, Hye Soo
    Seo, Ji-A
    Kim, Sin Gon
    Kim, Nan Hee
    Baik, Sei Hyun
    Choi, Dong Seop
    Choi, Kyung Mook
    PLOS ONE, 2017, 12 (04):